|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Contingent consideration receivable | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Inventory, non-current | ||||||||||||||||||||
| Royalty receivable, non-current | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use asset, net | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Long-term investments | ||||||||||||||||||||
| Deferred tax asset, non-current | ||||||||||||||||||||
| Non-current assets held for sale | ||||||||||||||||||||
| Acquired intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and related benefits | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||||
| Deferred grant income, current | ||||||||||||||||||||
| Term loan, current | ||||||||||||||||||||
| Convertible notes, current | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible Notes Payable, Noncurrent | ||||||||||||||||||||
| Convertible notes, non-current | ||||||||||||||||||||
| Term loan, non-current | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Deferred grant income, non-current | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Non-current liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable preferred stock: $0.001 par value; zero and 256 shares authorized, issued and outstanding at December 31, 2024 and 2023, respectively; aggregate liquidation preference of zero and $255,559 at December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock: $0.001 par value, 10,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock: $0.001 par value, 600,000 shares authorized at June 30, 2026 and December 31, 2025; 410,701 and 404,961 shares issued at June 30, 2026 and December 31, 2025, respectively; 392,121 and 386,381 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock at cost: 18,580 shares at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
